DJ Biogen Posts Higher 4Q Earnings >BIIB
By Amber Burton
Biogen Inc. (BIIB) reported higher earnings in the latest quarter, beating analysts' expectations.
The Cambridge, Mass., biopharmaceutical company on Thursday said its fourth-quarter earnings were $1.44 billion, or $8.08 a share, compared with $947 million, or $4.73 a share a year earlier.
Adjusted earnings for the quarter were $8.34 a share. Analysts polled by FactSet were expecting adjusted earnings of $8.02 a share.
Total revenue was $3.67 billion, up from $3.53 billion a year earlier. Analysts were expecting revenue of $3.54 billion.
Write to Amber Burton at amber.burton@wsj.com
(END) Dow Jones Newswires
January 30, 2020 07:19 ET (12:19 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
DJ生物源职位较高的4Q收入>BIIB
作者：Amber Burton
生物原公司BIIB(BIIB)报告称，上一季度盈利较高，超出分析师预期。
这家马萨诸塞州剑桥生物制药公司周四宣布，其第四季度利润为14.4亿美元，合每股8.08美元，而去年同期为9.47亿美元，合每股4.73美元。
该季度调整后的收益为每股8.34美元。FactSet调查的分析师预计调整后的每股收益为8.02美元。
总收入为36.7亿美元，高于去年同期的35.3亿美元。分析师预计营收为35.4亿美元。
电邮：amber.burton@wsj.com
(完)道琼斯通讯社
2020年1月30日07：19(格林尼治时间12：19)
版权(C)2020 DowJones&Company，Inc.
使用浏览器的分享功能，分享给你的好友吧